U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06822049) titled 'Remote Vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)' on Feb. 06.
Brief Summary: The study will employ a randomized, parallel-group design with two-stage randomization. After an initial brief screen for basic eligibility, participants will be randomized (within site) to either Remote (R) or In-Person (IP) Intake Groups. During the Intake, detailed consent and eligibility assessment will be completed. Participants who are eligible at the Intake will be randomized (within site and Intake Group) to R or IP Treatment and Assessment Groups. Participants will be followed for 3 months.
Study Start Date: Feb. 0...